Souhaitez-vous accéder aux communiqués récents ?

ETX-312 well tolerated at exaggerated dose levels in GLP-compliant toxicology studies GMP manufacturing of clinical trial batch successfully completed On track for CTA submission in Q4 2025 ...

Ichnos Glenmark Innovation (IGI) and AbbVie Announce Exclusive Global Licensing Agreement for ISB 2001, a First-in-Class CD38×BCMA×CD3 Trispecific Antibody

Joint research program targets new treatments for life-threatening complication of brain hemorrhage An international discovery collaboration is harnessing AI-powered drug discovery to develop a...

Cambridge, Mass., July 02, 2025 (GLOBE NEWSWIRE) -- A team of researchers from the MIT Sloan School of Management, the Sean M. Healey & AMG Center for ALS at Massachusetts General Hospital...

• RC/XAI™ Next-generation risk-aware XAI for mission-critical applications • Advances trust and transparency in high-stakes decision making equity market trading REDMOND, Wash., July 02, 2025 ...

Dublin, July 02, 2025 (GLOBE NEWSWIRE) -- The "FDA Inspection Preparedness and Compliance" training has been added to ResearchAndMarkets.com's offering. This is a practical, hands-on two-day...

Dublin, July 01, 2025 (GLOBE NEWSWIRE) -- The "Pharmacovigilance World 2025" conference has been added to ResearchAndMarkets.com's offering. We are delighted to welcome you to the...

Boston, June 27, 2025 (GLOBE NEWSWIRE) -- According to the latest study from BCC Research, “Biosimilars: Global Markets” is expected to grow from $28.5 billion in 2024 to $69.2 billion by the end of...

Dublin, June 25, 2025 (GLOBE NEWSWIRE) -- The "Common Technical Document (CTD) Submission in the MENA Region Training Course (ONLINE EVENT: July 1, 2025)" has been added to ResearchAndMarkets.com's...

MDR-001 achieved statistically significant weight reductions of 8.2% to 10.3% at 24 weeks compared to 2.5% with placebo (p<0.00001), with up to 48.1% of participants achieving ≥10% weight loss.No...